Ocular Therapeutix
OCUL
OCUL
153 hedge funds and large institutions have $774M invested in Ocular Therapeutix in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 55 increasing their positions, 45 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
4.87% less ownership
Funds ownership: 66.98% → 62.11% (-4.9%)
26% less capital invested
Capital invested by funds: $1.04B → $774M (-$269M)
60% less funds holding in top 10
Funds holding in top 10: 10 → 4 (-6)
Holders
153
Holding in Top 10
4
Calls
$10.3M
Puts
$9.14M
Top Buyers
| 1 | +$7.58M | |
| 2 | +$6.28M | |
| 3 | +$6.02M | |
| 4 |
BlackRock
New York
|
+$5.82M |
| 5 |
Two Sigma Investments
New York
|
+$4.07M |
Top Sellers
| 1 | -$30.3M | |
| 2 | -$24.3M | |
| 3 | -$17.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$15.4M |
| 5 |
D.E. Shaw & Co
New York
|
-$6.52M |